Hainan Poly Pharm. Co., Ltd

XSEC:300630 Stock Report

Market Cap: CN¥4.7b

Hainan Poly Pharm Future Growth

Future criteria checks 3/6

Hainan Poly Pharm is forecast to grow earnings at 105.6% per annum. EPS is expected to grow by 106% per annum.

Key information

105.6%

Earnings growth rate

106.0%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updated08 Jul 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300630 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,307-106-322-198N/A
6/30/20241,272-68-279-174N/A
3/31/20241,39686-301-54N/A
12/31/20231,30486-435113N/A
9/30/2023872-67-426283N/A
6/30/20231,294104-504337N/A
3/31/20231,466200-837261N/A
12/31/20221,619295-809228N/A
9/30/20221,743482-86983N/A
6/30/20221,681479-950166N/A
3/31/20221,603457-689168N/A
1/1/20221,509417-647157N/A
9/30/20211,543513-737380N/A
6/30/20211,410474-571343N/A
3/31/20211,291449-495337N/A
12/31/20201,189407-504332N/A
9/30/20201,124380-385251N/A
6/30/20201,000340-356228N/A
3/31/2020964311-355217N/A
12/31/2019950301-187215N/A
9/30/2019830266-16121N/A
6/30/2019725231-197102N/A
3/31/2019687220-14098N/A
12/31/2018624181-15795N/A
9/30/2018528159-185206N/A
6/30/2018445137N/A99N/A
3/31/2018371119N/A95N/A
12/31/201732598N/A94N/A
9/30/201729889N/A84N/A
6/30/201727578N/A74N/A
3/31/201726072N/A56N/A
12/31/201624870N/A56N/A
6/30/201621456N/A43N/A
3/31/201619350N/A47N/A
12/31/201520351N/A58N/A
12/31/201416537N/A57N/A
12/31/201313225N/A45N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300630 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).

Earnings vs Market: 300630 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 300630 is expected to become profitable in the next 3 years.

Revenue vs Market: Insufficient data to determine if 300630's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 300630's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300630's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y